S. Biswal, M. Panda, R. K. Sahoo, S. K. Tripathi, and B. K. Biswal,"Tumour microenvironment and aberrant signaling pathways in cisplatin resistance and strategies to overcome in oral cancer", Archives of Oral Biology, vol.151, Elsevier, July 2023, https://doi.org/10.1016/j.archoralbio.2023.105697       Article

S. Mund, K. Singh, M. Panda, B. K. Biswal, U. Subuddhi, and V. S. Kumar,"Thiabendazole: a new class of antenna core structure for multifunctional trivalent organo-europium (EuIII) complexes", Journal of Materials Chemistry C, RSC, June 2022, DOI https://doi.org/10.1039/D2TC01078J       Article

S. Kanttripathi, R. K. Sahoo, and B. K. Biswal,"SOX9 as an emerging target for anticancer drugs and a prognostic biomarker for cancer drug resistance", Drug Discovery Today, Elsevier 2022, https://doi.org/10.1016/j.drudis.2022.05.022       Article

M. Panda and B. K. Biswal,"Evodiamine inhibits stemness and metastasis by altering the SOX9–ß-catenin axis in non-small-cell lung cancer", Journal of Cellular Biochemistry, Wiley 2022, https://doi.org/10.1002/jcb.30304       Article

M. Panda, S. K. Tripathi, G. Zengin, and B. K. Biswal,"Evodiamine as an anticancer agent: a comprehensive review on its therapeutic application, pharmacokinetic, toxicity, and metabolism in various cancers.", Cell Biology and Toxicology, Springer, September 2022, 10.1007/s10565-022-09772-8       Article

S. K. Padhan, J. Bag, M. Panda, B. K. Biswal, H. Sahoo, M. Mishra, and S. N. Sahu,"Synthesis of First Coumarin Fluorescent Dye for Actin Visualization.", Bioconjugate Chemistry, ACS, October 2022, 10.1021/acs.bioconjchem.2c00332       Article

M. Panda, S. K. Tripathi, and B. K. Biswal,"SOX9: An emerging driving factor from cancer progression to drug resistance", Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, vol.1875, Elsevier, April 2021, https://doi.org/10.1016/j.bbcan.2021.188517       Article

S. K. Tripathi and B. K. Biswal,"Allosteric mutant-selective fourth-generation EGFR inhibitors as an efficient combination therapeutic in the treatment of non-small cell lung carcinoma", Drug Discovery Today, vol.26, Elsevier, June 2021, https://doi.org/10.1016/j.drudis.2021.02.005       Article

S. K. Tripathi and B. K. Biswal,"SOX9 promotes epidermal growth factor receptor-tyrosine kinase inhibitor resistance via targeting ß-catenin and epithelial to mesenchymal transition in lung cancer", Life Sciences, vol.277, Elsevier, July 2021       Article

S. Chabattula, P. Gupta, S. Tripathi, R. Gahtori, P. Padhi, S. Mahapatra, B. K. Biswal, S. Singh, K. Dua, J. Ruokolainen, Y. Mishra, N. Jha, D. Bishi, and K. Kesari,"Anticancer therapeutic efficacy of biogenic Am-ZnO nanoparticles on 2D and 3D tumor models", Materials Today Chemistry, vol.22, no.100618, Elsevier, December 2021, https://doi.org/10.1016/j.mtchem.2021.100618       Article